JNJ-63871860

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JNJ-63871860, covering 2020-04-22 to 2020-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Adults to Evaluate the Safety and Immunogenicity of Different Doses of JNJ-63871860 [Phase 2]